Prostate Tumors
Original Article Obesity inhibits lymphangiogenesis in prostate tumors
... in prostate tumors induced in ...the prostate cancer dissemination as already suggested by our previous research [10] and some epidemio- logical studies ...
5
Arum Palaestinum with isovanillin, linolenic acid and β sitosterol inhibits prostate cancer spheroids and reduces the growth rate of prostate tumors in mice
... for prostate cancer with activation of caspase 6, as well as in vivo tumor suppression of prostate cancer in ...with prostate cancer. In fact, out of 107 prostate human adenocarcinomas ...
8
The Role of Cytokeratin 5/6 in Differential Diagnosis of Prostate Tumors
... Sixty paraffin blocks were selected from patients samples affected with prostate tumor. Sections were cut then stained using immunohistochemical method (new indirect method) to detect cytokeratin5/6 expression in ...
8
Detection of Acidic Mucins and Corpora Amylacea in Prostate Tumors
... The age of the study population ranged between 50 and 86, with mean age 69 ± 9. Most patients were aggregating in the age more than 65 years representing 71.8%, and the rest were less than 65 years representing 28.2%, ...
10
Immunohistochemical Detection of Androgen Receptors in Prostate Tumors
... This study aimed to detect the expression of androgen receptors (AR) in prostate tumors. Forty formalin fixed paraffin blocks (FFPB) previously diagnosed as prostate tumors were selected for ...
9
Prostate Tumors Diagnosis: Place of Fine Needle Aspiration in Congolese Patients
... the prostate, which by cytology, also allows the diagnosis of orientation or presumption emergency prostate tumors [13] and especially pending histological ...of prostate cancer remains ...
15
The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases
... in prostate tumors, one generally diffused and a more peripheral with a doughnut-shaped ...the prostate and beyond the ...PSMA-based prostate imaging might detect extra-capsular extension, a ...
13
Autologous dendritic cells transfected with prostate specific antigen RNA stimulate CTL responses against metastatic prostate tumors
... circulating prostate tumor cell upon initiation of systemic chemotherapy or androgen ablation (unpublished ...all prostate cancer patients, particularly those with minimal tumor burdens, will have ...
10
Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer
... metastasized tumors are known to display both epithelial and mesenchymal phenotypes including morphology and gene expression profiles, and metastatic prostate tumors are likely comprised of ...
14
Androgen deprivation–induced NCoA2 promotes metastatic and castration resistant prostate cancer
... advanced prostate cancer (PCa) in patients is the resistance of tumors to androgen deprivation therapy (ADT) and their subsequent development into castration-resistant prostate cancer ...the ...
15
Key Plants in Fighting Cancer in the Middle East
... Properties and ethno-botanical uses: Origanum majorana is used as an aphrodisiac, emmenagogue, tonic, hemorrhoid treatment, carminative, diuretic, and stimulant [37]. It is also used in the treatment of kidney stones, ...
12
siAh in prostAte cAncer development And progression
... lesions: prostate NE carcinoma and atypical hyperplasia ...of prostate NE carcinoma in TRAMP mice, while AH lesions were less ...NE tumors showed reduced HIF-1 α levels, decreased cell proliferation, ...
7
Cervical lymphadenopathy as initial presentation of genito-urinary cancer
... enlarged prostate weighing 68 gm. The prostate specific antigen (PSA) was ...guided prostate biopsy revealed adenocarcinoma of prostate, gleason ...
6
Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist 68Ga-RM2 And PET
... Albeit our findings warrant verification by larger patient series, it is tempting to speculate about potential clinical indications of GRPR PET in BC patients. For instance, in clinical practice the hormone receptor ...
10
Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer
... brain tumors and the stroma of various types of cancer including melanoma, prostate, breast, testicular, colon, pancreatic, and gastric cancers and are known to play important roles in tumor growth and ...
17
Effectiveness and Safety of CT Guided 125I Brachytherapy for Lung Metastasis from Hepatocellular Carcinoma
... 125I brachytherapy has been widely applied for tumor treatment in clinic with significant efficacy providing promising results for local control of solid tumors such as prostate carcinom[r] ...
6
Klutz, Kathrin (2010): Molecularly targeted imaging and radionuclide therapy of non-thyroidal tumors following viral and non-viral sodium iodide symporter (NIS) gene delivery. Dissertation, LMU München: Fakultät für Chemie und Pharmazie
... the prostate-specific antigen (PSA) promoter, the carcinoembryonic antigen (CEA) promoter and the calcitonin promoter to specifically target NIS expression to prostate, colon and medullary thyroid cancer, ...
131
Eradicating Metastatic Cancer and the Evolutionary Dynamics of Extinction
... For decades, cancer therapists have focused on development of new drugs as the most productive strategy to improve outcomes in treatment of disseminated, metastatic cancers. The success and failure of these efforts is ...
14
A Novel Protease Homolog Differentially Expressed in Breast and Ovarian Cancer
... Protease M mRNA was expressed in normal breast and prostate cell strains but not in cell lines derived from metastatic tumors. The basis for this down-regulation is not known; however,[r] ...
13
Organ transplantation from deceased donors with cancer: is it safe?
... late-onset tumors (such as 10 years post-transplant), estimated tumor doubling times suggest that no mass lesion existed at the time of ...donor-origin tumors arising within a 2-year post-transplant period ...
10